These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38573268)

  • 21. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany.
    Michel A; Lecomte C; Ohlmeier C; Raad H; Basedow F; Haeckl D; Beier D; Evers T
    Am J Cardiovasc Drugs; 2024 May; 24(3):409-418. PubMed ID: 38573461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
    Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
    Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reasons for not prescribing guideline-recommended medications to adults with heart failure.
    Steinman MA; Dimaano L; Peterson CA; Heidenreich PA; Knight SJ; Fung KZ; Kaboli PJ
    Med Care; 2013 Oct; 51(10):901-7. PubMed ID: 23969589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication Adherence.
    Lu L; Jackevicius CA; de Leon NK; Warner AL; Chang DS; Mody FV
    Clin Ther; 2017 Jun; 39(6):1200-1209. PubMed ID: 28545803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
    McMurray J; Cohen-Solal A; Dietz R; Eichhorn E; Erhardt L; Hobbs FD; Krum H; Maggioni A; McKelvie RS; Piña IL; Soler-Soler J; Swedberg K
    Eur J Heart Fail; 2005 Aug; 7(5):710-21. PubMed ID: 16087129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
    Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
    J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy modifications during hospitalization in patients with chronic heart failure.
    Detiček A; Locatelli I; Roblek T; Mrhar A; Lainscak M
    Eur J Intern Med; 2016 Apr; 29():52-8. PubMed ID: 26775137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure clinics improve use of evidence-based heart failure therapies in patients with reduced ejection fraction following acute coronary syndrome (ANZACS-QI 48).
    Chan D; Doughty RN; Mazengarb J; McLachlan A; Kerr AJ
    N Z Med J; 2020 Jun; 133(1516):58-71. PubMed ID: 32525862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical therapy doses at hospital discharge in patients with existing and de novo heart failure.
    Diamant MJ; Virani SA; MacKenzie WJ; Ignaszewski A; Toma M; Hawkins NM
    ESC Heart Fail; 2019 Aug; 6(4):774-783. PubMed ID: 31218850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
    Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
    JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between process quality measures for heart failure and mortality among US veterans.
    Wu WC; Jiang L; Friedmann PD; Trivedi A
    Am Heart J; 2014 Nov; 168(5):713-20. PubMed ID: 25440800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-year time trends in use of evidence-based heart failure drug therapy in Denmark.
    Vinter N; Jensen M; Skjøth F; Larsen TB; Frost L; Johnsen SP
    Basic Clin Pharmacol Toxicol; 2020 Jul; 127(1):30-38. PubMed ID: 32003944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalizable Approach to Quantifying Guideline-Directed Medical Therapy.
    Khan MS; Chan PS; Sherrod CF; Ikemura N; Sauer AJ; Jones PG; Fonarow GC; Butler J; DeVore AD; Lund LH; Spertus JA
    Circ Heart Fail; 2024 May; 17(5):e011164. PubMed ID: 38742418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry.
    Pierce JB; Ikeaba U; Peters AE; DeVore AD; Chiswell K; Allen LA; Albert NM; Yancy CW; Fonarow GC; Greene SJ
    JAMA Cardiol; 2023 Apr; 8(4):376-385. PubMed ID: 36806447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
    Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
    J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.
    Quiroga B; Ortiz A; Núñez S; Kislikova M; González Sanchidrián S; Broseta JJ; Albines ZS; Escamilla Cabrera B; Rivero Viera Y; Rodriguez Santarelli D; Salanova Villanueva L; Lopez Rodriguez F; Cancho Castellano B; Ibáñez Cerezon M; Gutierrez Rivas CP; Aresté N; Campos Gutiérrez B; Ródenas Gálvez A; Glucksmann Pizá MC; Balda Manzanos S; Soldevila A; Rodríguez Gayo L; Moral Berrio E; Ortega Diaz M; Beltrán Catalán S; Puente García A; Ángel Rojas M; Sosa Barrios RH; Santana Zapatero H; Rangel Hidalgo G; Martinez Canet AM; Díez J;
    Cardiorenal Med; 2024; 14(1):202-214. PubMed ID: 38513622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.